About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Plus Therapeutics Inc (NQ: PSTV )

1.860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.860
Bid (Size) 1.680 (25)
Ask (Size) 2.150 (1)
Prev. Close 1.860
Today's Range 1.860 - 1.860
52wk Range 0.9694 - 3.210
Shares Outstanding 2,879,620
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PSTV Stock Earnings: Plus Therapeutics Beats EPS, Misses Revenue for Q1 2024
PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion. 
Via Benzinga

Performance

YTD
+0.54%
+0.54%
1 Month
-12.68%
-12.68%
3 Month
+2.20%
+2.20%
6 Month
-1.59%
-1.59%
1 Year
-38.41%
-38.41%

More News

Read More
PSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Recap: Plus Therapeutics Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
Via Benzinga
Topics Stocks
Exposures US Equities
Why Plus Therapeutics Stock Popped Today
Via Benzinga
Earnings Outlook For Plus Therapeutics
Via Benzinga
Earnings Scheduled For March 5, 2024
Via Benzinga
Plus Therapeutics Earnings Preview
Via Benzinga
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Scheduled For October 31, 2023
Via Benzinga
Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
Via Benzinga
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.